🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Carvedilol is a non-selective beta-blocker in common clinical use, used to ...
Status
Completed
Location
Department of Clinical Pharmacology
Start Date
2024-08-22
Trial ID
NCT06566794
This study is conducted in Africa and Asia. The aim of this study is to eva...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2004-08
Trial ID
NCT01498900
Treatments Being Tested
This study will assess the effect of AZD5004 on Rosuvastatin, Atorvastatin,...
Status
Completed
Location
Research Site
Start Date
2025-05-06
Trial ID
NCT06948747
Treatments Being Tested
This trial is conducted in Asia. The aim of this trial is to compare oral a...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2002-09-19
Trial ID
NCT01720303
Treatments Being Tested
The study aims to descibe the pharmacokinetics of 10 substrates of enzymes ...
Status
Completed
Location
Center of clinical investigation
Start Date
2010-08
Trial ID
NCT01188525
Treatments Being Tested
This study is conducted in Asia. The aim of this study is to review the saf...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2001-08-30
Trial ID
NCT01498913
Treatments Being Tested
The purpose of this study is to prevent major cardiovascular events (heart ...
Status
Completed
Location
Minneapolis Medical Research Foundation
Start Date
1999-09
Trial ID
NCT00000620
The main purpose of this study is to assess the effect of selpercatinib on ...
Status
Completed
Location
Celerion
Start Date
2019-01-29
Trial ID
NCT05469113
Treatments Being Tested
To assess the effect of adding acarbose or repaglinide or gliclazide to sit...
Status
Completed
Location
Multiple Locations
Start Date
2012-11-08
Trial ID
NCT01709305
Treatments Being Tested
The purpose of this study is to assess the effect of multiple doses of gana...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-03-09
Trial ID
NCT05236530